e-Drug3D 1295 |
TIOTROPIUM
|
cas 186691-13-4 |
CLASS RESPIRATORY |
ROUTE (list) INHALATION |
PK parameters F 19.5 PERCENT (INHALATION) AND 2.5 PERCENT (ORAL) Solubility SPARINGLY SOLUBLE IN WATER |
Target TARGET MUSCARINIC ACETYLCHOLINE RECEPTOR (M1-M5) PDB Ligand code = 0HK (link to the list of PDB complexes) Download experimental 3D coordinates of 0HK with added hydrogens |
DrugCentral Muscarinic acetylcholine receptor M3 UNIPROT P20309 CHRM3 |
Download SDF file | 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)- Formula: Calculated chemical properties: MW 392.52 NB_atoms 26 XLogP 2.35 PSA 49.347 NB_HD 1 NB_HA 4 fsp3 0.53 Lipinski(0=no;1=yes) 1 |
FDA NDA 021395 (label) INN (TIOTROPIUM BROMIDE) SPIRIVA (BOEHRINGER INGELHEIM) APPROVAL= AP YEAR= 2004 NEWMOLECULARENTITY NDA 021936 (label) INN (TIOTROPIUM BROMIDE) SPIRIVA RESPIMAT (BOEHRINGER INGELHEIM) APPROVAL= AP YEAR= 2014 NDA 206756 (label) INN (OLODATEROL HYDROCHLORIDE ; TIOTROPIUM BROMIDE) STIOLTO RESPIMAT (BOEHRINGER INGELHEIM) APPROVAL= AP YEAR= 2015 NDA 207070 (label) INN (TIOTROPIUM BROMIDE) SPIRIVA RESPIMAT (BOEHRINGER INGELHEIM) APPROVAL= AP YEAR= 2015 NEWAPPLICATION NDA 211287 (pdf not found) INN (TIOTROPIUM BROMIDE) TIOTROPIUM BROMIDE (LUPIN) APPROVAL= AP YEAR= 2023 |
Other links: |